Prednisolone Dosing for 33.62 kg Patient
For a patient weighing 33.62 kg, the appropriate prednisolone dose depends entirely on the specific condition being treated, as dosing ranges from 0.14-2 mg/kg/day across different indications.
Dose Calculation Framework
Without knowing the specific diagnosis, I'll provide the most common pediatric dosing scenarios for this weight:
Standard Pediatric Dosing by Indication
For severe inflammatory/autoimmune conditions:
- 1-2 mg/kg/day: 33.6-67.2 mg/day (11.2-22.4 mL of 15mg/5mL suspension) 1, 2
- Maximum typically capped at 60 mg/day in many protocols 1, 3
For moderate inflammatory conditions:
- 0.5-1 mg/kg/day: 16.8-33.6 mg/day (5.6-11.2 mL) 4
For mild conditions or maintenance:
- 0.14-0.5 mg/kg/day: 4.7-16.8 mg/day (1.6-5.6 mL) 3
Specific Disease Examples
Nephrotic Syndrome (Initial Episode):
- 60 mg/m² BSA/day is the guideline-recommended dose 2, 5
- For 33.62 kg child: approximately 40-50 mg/day (13.3-16.7 mL)
- Note: 2 mg/kg/day (67.2 mg) is NOT equivalent to 60 mg/m²/day in children <30 kg 5
Asthma Exacerbation:
- 1-2 mg/kg/day: 33.6-67.2 mg/day for 3-10 days 3, 6
- Evidence supports 1 mg/kg/day as effective with fewer side effects than 2 mg/kg/day 6
Autoimmune Hepatitis:
- Initial: 1-2 mg/kg/day (up to 60 mg/day): 33.6-60 mg/day (11.2-20 mL) 1
- Taper over 6-8 weeks to maintenance of 0.1-0.2 mg/kg/day
Critical Dosing Considerations
Volume Calculation with 15 mg/5 mL Suspension
- Concentration: 3 mg/mL
- Example: For 30 mg dose = 10 mL; for 45 mg dose = 15 mL; for 60 mg dose = 20 mL
Common Pitfalls to Avoid
BSA vs. Weight-Based Dosing: In children <30 kg, weight-based dosing (2 mg/kg) delivers significantly less drug than BSA-based dosing (60 mg/m²) 5. Use BSA calculations for nephrotic syndrome specifically.
Maximum Daily Dose: Most pediatric protocols cap at 60 mg/day regardless of calculated dose 1, 3
Divided vs. Single Daily Dose: Give as single morning dose for most conditions 1, 2. Only divide doses for specific protocols (e.g., nephrotic syndrome may use 3 divided doses initially) 3.
Duration Matters: Short courses (3-14 days) require different considerations than chronic therapy. Doses >0.5 mg/kg/day for >3 weeks require tapering 7, 3.
Dose-Dependent Adverse Effects
- 10 mg/day: Minimal metabolic impact 8
- 15-20 mg/day: Clinically significant insulin resistance and bone turnover effects 8
- >0.5 mg/kg/day for >3 weeks: Risk of HPA axis suppression requiring stress dosing 7
Practical Dosing Algorithm
Step 1: Identify the specific diagnosis Step 2: Determine disease severity (mild/moderate/severe) Step 3: Calculate appropriate dose:
- Severe disease: 1-2 mg/kg/day (max 60 mg)
- Moderate disease: 0.5-1 mg/kg/day
- Mild disease: 0.14-0.5 mg/kg/day
Step 4: Convert to volume: Divide mg dose by 3 to get mL Step 5: Administer as single morning dose unless protocol specifies otherwise Step 6: Plan tapering schedule if treatment >2-3 weeks 3
Without the specific diagnosis, I cannot provide the exact dose for this patient. The prescriber must specify the indication to determine whether this patient needs 5 mL (15 mg), 10 mL (30 mg), 15 mL (45 mg), or 20 mL (60 mg) daily.